Effects of somatostatin on renal function in cirrhosis.
To investigate the renal effects of somatostatin in cirrhosis, renal function and plasma and urinary levels of endogenous neurohumoral vasoactive substances were measured in conditions of intravenous water overload (20 mL/kg body wt with 5% glucose) before and during the intravenous infusion of somatostatin (250-500 micrograms/h) in 6 cirrhotic patients without ascites and 17 nonazotemic cirrhotic patients with ascites. Somatostatin induced a significant reduction of renal plasma flow, glomerular filtration rate, and free water clearance in both groups of patients. In patients with ascites, somatostatin also reduced urinary sodium excretion. Changes in renal function were significantly more marked in patients with ascites than in those without ascites and occurred in the absence of changes in mean arterial pressure and plasma levels of renin, aldosterone, norepinephrine, antidiuretic hormone, and atrial natriuretic peptide. Somatostatin induced a significant reduction in the plasma concentration of glucagon and urinary excretion of prostaglandin E2 that was not related to changes in renal function. These findings indicate that somatostatin administration induces renal vasoconstriction and impairs glomerular filtration rate, free water clearance, and sodium excretion in cirrhosis by a mechanism unrelated to systemic hemodynamics and endogenous neurohumoral vasoactive systems.
Liver Unit, Hospital Clínic i Provincial, University of Barcelona, Spain.
A
A
Ginès
J M
JM
Salmerón
P
P
Ginès
W
W
Jiménez
J
J
Saló
C
C
Piera
J
J
Clària
F
F
Rivera
V
V
Arroyo
J
J
Rodés
D015232:Dinoprostone / Q000652:urine; D005919:Glomerular Filtration Rate / Q000187:drug effects; D005934:Glucagon / Q000097:blood; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000503:physiopathology*; D012079:Renal Circulation / Q000187:drug effects; D013004:Somatostatin / Q000494:pharmacology* / Q000627:therapeutic use
D013004:Somatostatin; D005934:Glucagon; D015232:Dinoprostone